EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Immune checkpoint inhibitor-related myocarditis: a comprehensive analysis of clinical manifestations and prognostic factors

Yue Fan, Yan Xu, Xiaoyan Liu, Guangcheng Liu, Bin Zhang, Wei Wu iD, Shuyang Zhang iD

The Oncologist · 01.10.2025 · 30 (10)

DOI: 10.1093/oncolo/oyaf285 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Oncologist, online erschienen am 25.09.2025. Verfasst von Yue Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730…. Hauptthemen laut MEDLINE: Myocarditis, Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, National Science and Technology Major Project of China, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immune checkpoint inhibitors-related myocarditis (ICI-myocarditis) is a rare but potentially lethal complication of cancer immunotherapy. Extensive information concerning risk factors and outcomes is still insufficient.

Methods

This multicenter retrospective study enrolled 161 patients diagnosed with biopsy-proven or clinically diagnosed ICI-myocarditis. We performed thorough studies of clinical characteristics and management approaches. Time-to-event analyses, encompassing landmark analysis, and competing risk models, were employed to identify early mortality predictors and evaluate long-term prognosis in survivors.

Results

ICI-myocarditis typically generally manifested early (median 4 weeks following ICI initiation), with mortality primarily occurring within 60 days. Significantly elevated cardiac troponin I (cTnI ≥ 50 times the upper reference limit) and reduced left ventricular ejection fraction (LVEF < 50%) were strong predictors of shortened survival. Landmark analyses revealed these factors influenced early but not long-term mortality beyond 60 days. Patients with concomitant myositis exhibited more fulminant presentations and higher early mortality, though long-term outcomes were comparable to those of isolated myocarditis. Multivariable analysis identified four independent predictors of cardiotoxicity-related death: initial LVEF < 50%, alanine aminotransferase (ALT), creatine kinase-MB (CKMB), and concomitant ICI-myositis.

Conclusions

Our study identifies multiple key predictors of early mortality in ICI-myocarditis. These results underscore the significance of early detection and vigorous intervention, particularly in patients with extreme troponin elevation or overlapping myositis. Despite higher short-term mortality in high-risk patients, long-term prognosis among survivors appears comparable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisImmune Checkpoint InhibitorsNeoplasmsHumansMaleFemalePrognosisMiddle AgedRetrospective StudiesAgedAdultRisk Factors

Stichwörter der Autor:innen

cardiac troponincardiotoxicityimmune checkpoint inhibitor-related myocarditisimmunotherapymyositis

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

ORCID-Profile: Wei Wu, Shuyang Zhang

Förderung

  • National High Level Hospital Clinical Research Funding
  • National Science and Technology Major Project of China
  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences

Zitieren

APA

Fan, Y., Xu, Y., Liu, X., Liu, G., Zhang, B., Wu, W., & Zhang, S. (2025). Immune checkpoint inhibitor-related myocarditis: a comprehensive analysis of clinical manifestations and prognostic factors. The Oncologist, 30(10). https://doi.org/10.1093/oncolo/oyaf285

Vancouver

Fan Y, Xu Y, Liu X, Liu G, Zhang B, Wu W, et al. Immune checkpoint inhibitor-related myocarditis: a comprehensive analysis of clinical manifestations and prognostic factors. The Oncologist. 2025;30(10). doi:10.1093/oncolo/oyaf285

BibTeX
@article{Fan2025,
  author = {Fan, Yue and Xu, Yan and Liu, Xiaoyan and Liu, Guangcheng and Zhang, Bin and Wu, Wei and Zhang, Shuyang},
  title = {Immune checkpoint inhibitor-related myocarditis: a comprehensive analysis of clinical manifestations and prognostic factors},
  journal = {The Oncologist},
  year = {2025},
  volume = {30},
  number = {10},
  doi = {10.1093/oncolo/oyaf285}
}
Kostenlos starten →